Targeting the PI3K/Akt/mTOR Pathway in Hepatocellular Carcinoma

Despite advances in the treatment of cancers through surgical procedures and new pharmaceuticals, the treatment of hepatocellular carcinoma (HCC) remains challenging as reflected by low survival rates. The PI3K/Akt/mTOR pathway is an important signaling mechanism that regulates the cell cycle, proli...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Eun Jin, Wankell, Miriam, Palamuthusingam, Pranavan, McFarlane, Craig, Hebbard, Lionel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615614/
https://www.ncbi.nlm.nih.gov/pubmed/34829868
http://dx.doi.org/10.3390/biomedicines9111639

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615614/
https://www.ncbi.nlm.nih.gov/pubmed/34829868
http://dx.doi.org/10.3390/biomedicines9111639

Ejemplares similares